{"id":"https://openalex.org/W2605098055","doi":"https://doi.org/10.1182/blood.v126.23.1277.1277","title":"Targeting BCL6-Mediated Resistance to BCR-ABL Targeted Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) through the Addition of Histone Deacetylase (HDAC) Inhibitors","display_name":"Targeting BCL6-Mediated Resistance to BCR-ABL Targeted Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) through the Addition of Histone Deacetylase (HDAC) Inhibitors","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2605098055","doi":"https://doi.org/10.1182/blood.v126.23.1277.1277","mag":"2605098055"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.1277.1277","doi":"https://doi.org/10.1182/blood.v126.23.1277.1277","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1277.1277","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Gordon Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gordon Cohen","raw_affiliation_strings":["Pediatric Hematology/Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Hematology/Oncology, Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091226342","display_name":"Colleen Annesley","orcid":"https://orcid.org/0000-0002-3473-0947","observed_orcids":["https://orcid.org/0000-0002-3473-0947"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen E. Annesley","raw_affiliation_strings":["Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036550103","display_name":"Rachel E. Rau","orcid":"https://orcid.org/0000-0003-4096-6603","observed_orcids":["https://orcid.org/0000-0003-4096-6603"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel E. Rau","raw_affiliation_strings":["Department of Pediatrics, Baylor College of Medicine, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Baylor College of Medicine, Houston, TX","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005360668","display_name":"Shannon M. Kelley","orcid":"https://orcid.org/0000-0002-2718-7560","observed_orcids":["https://orcid.org/0000-0002-2718-7560"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon Kelley","raw_affiliation_strings":["Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011067274","display_name":"Daniel Magoon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Magoon","raw_affiliation_strings":["Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007182073","display_name":"Patrick Andrew Brown","orcid":"https://orcid.org/0000-0002-8653-1069","observed_orcids":["https://orcid.org/0000-0002-8653-1069"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Brown","raw_affiliation_strings":["Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36390533,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"1277","last_page":"1277"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8076000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8076000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.15639999508857727,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-acute-lymphoblastic-leukemia","display_name":"Philadelphia chromosome-positive acute lymphoblastic leukemia","score":0.9200000166893005},{"id":"https://openalex.org/keywords/bcl6","display_name":"BCL6","score":0.9449999928474426},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.7820000052452087},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-resistance","display_name":"tyrosine kinase inhibitor resistance","score":0.8700000047683716},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.8849999904632568},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/entinostat","display_name":"entinostat","score":0.9950000047683716},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6710000038146973},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5609999895095825},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.5699999928474426},{"id":"https://openalex.org/keywords/adult-acute-lymphoblastic-leukemia","display_name":"adult acute lymphoblastic leukemia","score":0.44200000166893005},{"id":"https://openalex.org/keywords/pediatric-all","display_name":"pediatric ALL","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.743483304977417},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.697921633720398},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.5887212753295898},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.5403172969818115},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.5400789976119995},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.46961671113967896},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.45084503293037415},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4437192976474762},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37352830171585083},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.24329304695129395},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.16402196884155273},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1627613604068756},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13508862257003784},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.08790838718414307},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.1277.1277","doi":"https://doi.org/10.1182/blood.v126.23.1277.1277","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1277.1277","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2773127109","https://openalex.org/W2551002076","https://openalex.org/W2987852873","https://openalex.org/W2585105544","https://openalex.org/W2160248511","https://openalex.org/W1510801288","https://openalex.org/W2883039602","https://openalex.org/W2589075256","https://openalex.org/W3195838631","https://openalex.org/W2610427804"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Patients":[2],"who":[3],"harbor":[4],"the":[5,36,54,58,115,229,346,373,381,413,419,467,472,510,530,535,547,617],"Philadelphia":[6],"(Ph+)":[7],"chromosome":[8,38],"t(9;22)":[9],"translocation":[10],"account":[11],"for":[12],"approximately":[13],"20-30%":[14],"of":[15,20,28,60,118,127,146,204,231,300,303,326,372,442,457,462,489,558,563,570,581,597,662],"adult":[16],"ALL":[17,574,646],"and":[18,26,62,69,87,96,136,153,163,195,207,227,233,241,266,279,296,298,316,396,429,444,459,513],"2-5%":[19],"pediatric":[21],"ALL.":[22],"Prior":[23],"to":[24,66,94,160,175,187,236,360,452,636,664],"approval":[25],"use":[27],"imatinib,":[29,449,608],"a":[30,101,351,475,502,538,567,633],"small":[31],"molecule":[32],"TKI":[33,119],"which":[34],"targets":[35],"Ph+":[37,105,171,197,225,264,573,598,645],"BCR-ABL1,":[39],"these":[40],"patients":[41],"had":[42],"poor":[43],"survival":[44,51,75],"&":[45,74],"EFS":[46,73],"-":[47,80,433,438],"with":[48,190,277,331,436,448,583,605],"long":[49],"term":[50],"rates":[52,76],"in":[53,83,85,90,104,108,170,178,192,224,239,242,307,376,390,415,439,478,522,541,546,572,594,610,622,626,644,649],"20%":[55],"range.":[56],"With":[57],"addition":[59],"imatinib":[61,95,168,193,262,271,278,332,338,354,362,397],"later":[63],"generation":[64],"TKIs":[65,98,191,234],"chemotherapy":[67],"backbones":[68],"bone":[70,479,506],"marrow":[71,480,507],"transplant,":[72],"have":[77,184,214,592],"substantially":[78,369],"improved":[79],"surpassing":[81],"50%":[82],"studies":[84],"adults":[86],"even":[88,609],"higher":[89,352],"children.":[91],"However,":[92],"resistance":[93,123,437,571,643],"other":[97,122,208,514,552,641],"has":[99,157,613],"become":[100],"significant":[102,476,539,614],"problem":[103],"ALL,":[106,172,226],"especially":[107],"adults.":[109],"ABL1":[110,654],"kinase":[111,655],"domain":[112,656],"mutations":[113],"are":[114],"dominant":[116],"form":[117],"resistance,":[120],"however":[121],"mechanisms":[124,201],"include":[125],"upregulation":[126,428],"parallel":[128],"pathways":[129],"such":[130,150],"as":[131,151,491,585],"SRC":[132],"family":[133],"kinases,":[134],"MAPK":[135],"BCL6":[137,139,156,223,294,427,431,458,565,582],"pathways.":[138,212],"is":[140,566],"an":[141],"oncogene":[142],"that":[143,216,228,575,602],"suppresses":[144],"transcription":[145],"tumor":[147,464],"suppressor":[148],"genes":[149],"p53":[152],"CDNK1A.":[154],"Interestingly,":[155,616],"been":[158,185],"shown":[159,186,215,593],"be":[161,577],"upregulated":[162],"activated":[164,564],"through":[165],"deacetylation":[166],"following":[167,486],"treatment":[169,218,512,516],"likely":[173],"leading":[174],"its":[176],"role":[177],"resistance.":[179,363],"Histone":[180],"deacetylase":[181],"inhibitors":[182],"(HDACi)":[183],"act":[188],"synergistically":[189],"sensitive":[194,263],"resistant":[196,272,623],"leukemia":[198,601],"though":[199],"multiple":[200,394],"including":[202],"attenuation":[203],"BCR-ABL1":[205],"levels":[206],"downstream":[209,301,463],"proliferation":[210],"promoting":[211],"We":[213,425],"HDACi":[217,606],"acetylates":[219],"(and":[220,639],"thus":[221],"inactivates)":[222],"combination":[230,375,473,511,536,548,603,618,630],"HDACis":[232],"leads":[235],"synergistic":[237],"effects":[238],"vitro":[240,249],"vivo":[243,308],"(using":[244],"xenograft":[245,309,470,533,595],"models).":[246],"Methods:":[247],"In":[248,345,365,466,529],"WST-1":[250],"cell":[251],"viability":[252],"assays":[253],"were":[254,291,312,329],"carried":[255],"out":[256],"on":[257],"TOM1":[258,315,327,383,391,445,469],"cells":[259,268,318,379,392,417,446],"(non-ABL1":[260,269],"mutant,":[261,270],"ALL)":[265],"NALM1":[267,317,347,378,416,443,532],"CML":[273],"lymphoid":[274],"blast":[275,482,525,544],"crisis)":[276],"entinostat":[280,335,340,395,453],"(a":[281],"HDACi).":[282],"Synergy":[283],"was":[284,368,399,423,501,519],"assessed":[285],"using":[286],"Calcusyn":[287],"software.":[288],"Western":[289,440],"blots":[290,441],"performed":[292,313],"assessing":[293],"expression":[295,299,461],"acetylation,":[297],"effectors":[302],"apoptosis.":[304],"Two":[305],"separate":[306],"mouse":[310],"experiments":[311],"transplanting":[314],"into":[319],"Nod":[320],"SCID":[321],"Gamma":[322],"(NSG)":[323],"mice.":[324],"Cohorts":[325],"mice":[328,348],"treated":[330,447],"50mg/kg":[333],"BID,":[334],"15mg/kg":[336],"QD,":[337],"plus":[339],"combination,":[341],"or":[342],"vehicle":[343],"control.":[344],"we":[349,591],"added":[350],"dose":[353,421],"cohort":[355],"(100":[356],"mg/kg":[357],"BID)":[358],"due":[359],"known":[361,568],"Results:":[364],"vitro,":[366],"there":[367],"more":[370,620],"synergy":[371],"imatinib/entinostat":[374],"imatinib-resistant":[377,531,611],"vs.":[380],"imatinib-sensitive":[382,468,627],"cells.":[384],"Average":[385],"Combination":[386],"Index":[387],"(CI)":[388],"values":[389],"across":[393],"doses":[398],"1.2":[400],"(CI:":[401],"=1":[402],"suggest":[403],"additive":[404],"effect,":[405],"<1":[406],"=":[407,410],"synergy,":[408],">1":[409],"antagonism),":[411],"while":[412,450],"CI":[414],"at":[418],"same":[420],"combinations":[422],"0.53.":[424],"noted":[426],"decreased":[430,505],"acetylation":[432,456,580],"signs":[434],"correlating":[435],"exposure":[451],"caused":[454],"increased":[455,460],"suppressors.":[465],"trial,":[471,534],"displayed":[474],"reduction":[477],"leukemic":[481],"involvement":[483,508],"versus":[484,550],"control":[485],"6":[487],"weeks":[488,557],"dosing":[490],"measured":[492],"by":[493,579,653],"flow":[494],"cytometry":[495],"(36.9%":[496],"mean":[497],"decrease,":[498],"p=0.001).":[499],"There":[500,518],"trend":[503],"toward":[504],"between":[509,527],"active":[515,621],"arms.":[517,528],"no":[520],"difference":[521],"peripheral":[523,542],"blood":[524,543],"percentage":[526,545],"showed":[537],"decrease":[540],"arms":[549,553],"all":[551],"after":[554],"only":[555],"two":[556],"therapy":[559,604],"(p=0.0008).":[560],"Conclusions:":[561],"Upregulation":[562],"mechanism":[569],"may":[576],"abrogated":[578],"HDACi,":[584],"our":[586],"in-vitro":[587],"data":[588],"suggests.":[589],"Further,":[590],"models":[596],"acute":[599],"lymphoblastic":[600],"+":[607],"leukemia,":[612],"activity.":[615],"appears":[619],"disease":[624],"than":[625],"disease.":[628],"This":[629],"could":[631],"prove":[632],"viable":[634],"strategy":[635],"attenuate":[637],"imatinib-":[638],"perhaps":[640],"TKI-)":[642],"relapse,":[647],"particularly":[648],"cases":[650],"not":[651],"driven":[652],"mutations.":[657],"Disclosures":[658],"No":[659],"relevant":[660],"conflicts":[661],"interest":[663],"declare.":[665]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-14T00:00:00"}